TL;DR
A Monash University-led study across 31 Australian general practices found that a 12-month nurse-led program was associated with statistically significant improvement in participants’ estimated dementia risk scores compared with standard care. The trial measured risk profiles, not dementia diagnoses or prevention, and researchers say longer-term results are still needed.
A Monash University-led study found that a 12-month program delivered by general practice nurses improved estimated dementia risk scores among adults aged 45 to 65 with modifiable risk factors, compared with standard care. Published in The Lancet Regional Health – Western Pacific, the trial involved more than 403 people across 31 Australian practices; it assessed changes in risk profiles, not whether participants developed dementia or avoided cognitive decline.
Participants offered the intervention received five nurse consultations, an individual action plan and access to the HAPPI MIND app, which was designed for self-monitoring and goal tracking. The comparison group received standard risk-assessment results and educational material. The program aimed to help people identify health and lifestyle factors they could address and set practical goals with support from a nurse.
The study report said 56% of the intervention group showed improvement in their estimated risk profile, compared with 44% in the comparison group. Researchers reported a statistically significant improvement in risk scores relative to standard care. Changes in protective lifestyle measures—including physical activity, fish intake and body mass index status—accounted for much of the improvement reported in the intervention group.
The findings concern estimated risk measures over 12 months. They do not establish that the program prevents dementia, reduces the number of future diagnoses or slows cognitive decline. The researchers said planned follow-up data at 36 months will help show whether the early changes persist.
A Practical Role for General Practice
The results point to a potential way to bring dementia-risk reduction support into routine primary care, where adults can discuss several modifiable health factors with a nurse rather than receive information alone. The program combined personal consultations with a tool for tracking goals between appointments, offering a structured model that could be assessed for wider use.
The researchers also note that some targeted changes may benefit health beyond dementia risk. Senior CMUS Research Fellow Dr Amanda Cross said factors addressed by the trial can have more immediate relevance to cardiovascular and metabolic health. The study does not show that every participant will benefit equally, or that the model is ready for broad implementation; further evaluation is needed to establish lasting effects and practical delivery at scale.
The issue has public-health relevance in Australia. The Australian Institute of Health and Welfare estimates that 459,000 people are living with dementia in 2026, with the total projected to exceed one million by 2066. Those figures describe the national burden, not an outcome measured by this trial.
From Risk Advice to Nurse Support
The trial compared a more supported approach with a control group that received its standard risk-assessment results and educational material. In the intervention arm, nurses helped participants make a tailored action plan, while the app supported monitoring and goal-setting outside appointments. This design tested whether adding ongoing, personalized contact could improve estimated profiles beyond providing information alone.
The study sits alongside recent guidance on reducing risks linked to cognitive decline and dementia, including World Health Organization guidelines and an update to Australia’s Clinical Practice Guidelines for Dementia led by Monash researchers. Those developments provide a broader policy setting; they do not change the trial’s limits. Its reported findings are about risk-factor measures over one year, rather than clinical dementia outcomes.
“The findings suggest that personalized support through general practice may help people act on modifiable risk factors relevant to brain health.”
— Dr Muhammad Rehan Sarwar, lead author and CMUS research fellow
Long-Term Effects Still Unknown
The reported results do not show whether improvements in estimated risk scores lead to fewer dementia diagnoses or changes in cognitive decline over time. It is also not yet clear how much of the effect came from the nurse consultations, the action plans, the app or the combination of these elements. The source report does not provide detailed outcome estimates or confidence intervals, so the size and precision of the difference cannot be assessed from the information available here.
Researchers have said the trial’s planned 36-month follow-up will examine whether early improvements last. Until those data are reported, the durability of the changes and the program’s potential effect on long-term health outcomes remain unsettled.
Researchers Await 36-Month Data
The next reported milestone is analysis of follow-up data at 36 months, which researchers say will test whether the early risk-profile improvements persist. Those results may help clarify whether the program supports sustained changes beyond the initial year.
Any decision about wider delivery would also require evidence on long-term outcomes and how the approach works across different practices and patient groups. For now, the study supports further evaluation of nurse-led, app-assisted risk management; it does not establish a clinical dementia-prevention program.
Key Questions
What did the Monash University study find?
It reported a statistically significant improvement in estimated dementia risk scores after a 12-month nurse-led program, compared with standard care. The study included more than 403 adults aged 45 to 65 across 31 Australian general practices.
What did participants in the program receive?
They were offered five nurse consultations, a personalized action plan and access to the HAPPI MIND app for self-monitoring and goal tracking. The comparison group received standard risk-assessment results and educational material.
Does the study show that the program prevents dementia?
No. The trial measured changes in estimated risk profiles over 12 months, not dementia diagnoses or prevention of cognitive decline. Its findings should not be interpreted as proof that the program prevents dementia.
Did all participants improve?
No. The report said 56% of the intervention group showed improvement, compared with 44% in the comparison group. That means improvement was not reported for everyone, and the figures describe risk-profile change rather than clinical outcomes.
What happens next?
Researchers plan to examine 36-month follow-up data to see whether the early improvements last. The timing and results of that analysis were not specified in the source report.
Source: news-medical.net
